Xentria is a biotech company focused on developing novel therapeutics to address unmet clinical needs.
Xentria has raised $25.0M in total funding. The most recent round was Undisclosed. The last funding was announced in October 2022.
Xentria is headquartered in Chicago, United States.
Xentria is a biotech company focused on developing novel therapeutics to address unmet clinical needs.
Xentria is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xentria — Funding & Investors." VCBacked, October 18, 2022, https://www.vcbacked.co/company/xentria. Accessed September 16, 2026.
VCBacked. (2022). Xentria — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/xentria
{{cite web |title=Xentria — Funding & Investors |url=https://www.vcbacked.co/company/xentria |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated